FAMILIAL PULMONARY FIBROSIS
Clinical trials for FAMILIAL PULMONARY FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new FAMILIAL PULMONARY FIBROSIS trials appear
Sign up with your email to follow new studies for FAMILIAL PULMONARY FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Hope for High-Risk families: drug aims to stop lung scarring before it starts
Prevention Recruiting nowThis study tests a drug called nerandomilast in 80 people aged 40+ who have early lung changes and a family history of pulmonary fibrosis. Participants take either the drug or a placebo twice daily for up to 3 years. Doctors monitor lung function and scans to see if the drug slow…
Matched conditions: FAMILIAL PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC
-
Family lung disease study aims to uncover hidden risks
Knowledge-focused Recruiting nowThis study follows 750 healthy family members of people with familial pulmonary fibrosis, a lung scarring disease that runs in families. Researchers will track participants with yearly questionnaires and in-person visits every two years to see who develops the disease and why. Th…
Matched conditions: FAMILIAL PULMONARY FIBROSIS
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Scientists hunt for genetic clues in familial lung disease
Knowledge-focused Recruiting nowThis study aims to uncover the genetic causes of familial pulmonary fibrosis, a progressive lung disease that runs in families. Researchers will analyze DNA from 126 adults with a family history of the condition, looking for gene changes linked to lung scarring. The goal is to im…
Matched conditions: FAMILIAL PULMONARY FIBROSIS
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC